{"id":"https://openalex.org/W4213071640","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.tps218","title":"KEYNOTE-365 cohort I: Phase 1b/2 study of pembrolizumab combined with platinum-containing chemotherapy and chemotherapy alone for treatment-emergent neuroendocrine prostate carcinoma (t-NE).","display_name":"KEYNOTE-365 cohort I: Phase 1b/2 study of pembrolizumab combined with platinum-containing chemotherapy and chemotherapy alone for treatment-emergent neuroendocrine prostate carcinoma (t-NE).","publication_year":2022,"publication_date":"2022-02-16","ids":{"openalex":"https://openalex.org/W4213071640","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.tps218"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.6_suppl.tps218","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.tps218","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.6_suppl.tps218","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Johann S. De Bono","raw_affiliation_strings":["The Royal Marsden NHS Foundation Trust, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden NHS Foundation Trust, London, United Kingdom;","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085333470","display_name":"Anthony Michael Joshua","orcid":"https://orcid.org/0000-0001-5159-4580","observed_orcids":["https://orcid.org/0000-0001-5159-4580"]},"institutions":[{"id":"https://openalex.org/I4210087284","display_name":"St Vincent's Hospital Sydney","ror":"https://ror.org/000ed3w25","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210087284"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Anthony M. Joshua","raw_affiliation_strings":["St Vincent's Hospital Sydney, Sydney, NSW, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St Vincent's Hospital Sydney, Sydney, NSW, Australia;","institution_ids":["https://openalex.org/I4210087284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088518998","display_name":"Neal D. Shore","orcid":"https://orcid.org/0000-0001-5767-0548","observed_orcids":["https://orcid.org/0000-0001-5767-0548"]},"institutions":[{"id":"https://openalex.org/I4210165013","display_name":"Carolina Urologic Research Center","ror":"https://ror.org/05vk9vy20","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210165013"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neal D. Shore","raw_affiliation_strings":["Carolina Urologic Research Center, Myrtle Beach, SC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carolina Urologic Research Center, Myrtle Beach, SC;","institution_ids":["https://openalex.org/I4210165013"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071435826","display_name":"Gero Kramer","orcid":"https://orcid.org/0000-0003-1982-6817","observed_orcids":["https://orcid.org/0000-0003-1982-6817"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Gero Kramer","raw_affiliation_strings":["Medical University of Vienna, Vienna, Austria;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Vienna, Vienna, Austria;","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012899187","display_name":"Xin Tong Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xin Tong Li","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018436364","display_name":"Christian Heinrich Poehlein","orcid":"https://orcid.org/0000-0002-3348-3059","observed_orcids":["https://orcid.org/0000-0002-3348-3059"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christian Heinrich Poehlein","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059978899","display_name":"Charles Schloss","orcid":"https://orcid.org/0000-0002-5106-3082","observed_orcids":["https://orcid.org/0000-0002-5106-3082"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Schloss","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084909001","display_name":"Evan Y. Yu","orcid":"https://orcid.org/0000-0002-1510-8044","observed_orcids":["https://orcid.org/0000-0002-1510-8044"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evan Y. Yu","raw_affiliation_strings":["University of Washington, Seattle, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington, Seattle, WA;","institution_ids":["https://openalex.org/I201448701"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"6_suppl","first_page":"TPS218","last_page":"TPS218"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9179999828338623},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.7099999785423279},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.8809999823570251},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.996999979019165},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.7990000247955322},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9210000038146973},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6240000128746033},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.42899999022483826},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.4350000023841858},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.48399999737739563},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.628000020980835}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8996357917785645},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.8735276460647583},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8096232414245605},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6418948769569397},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6203240156173706},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.6091277599334717},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5911779999732971},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5813778042793274},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5727050304412842},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42326804995536804},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.11980780959129333},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.10678598284721375}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.6_suppl.tps218","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.tps218","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.6_suppl.tps218","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.7300000190734863,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3214158336","https://openalex.org/W3202169727","https://openalex.org/W4213208294","https://openalex.org/W4391303022","https://openalex.org/W4242199515","https://openalex.org/W4212935700","https://openalex.org/W4410811576","https://openalex.org/W3202260356","https://openalex.org/W4232022766","https://openalex.org/W3213792799"],"abstract_inverted_index":{"TPS218":[0],"Background:":[1],"In":[2,45],"previously":[3],"treated":[4],"adenocarcinoma":[5,63],"metastatic":[6,136],"castration-resistant":[7],"prostate":[8,138,158],"cancer":[9,139,159],"(mCRPC),":[10],"approximately":[11],"20%":[12],"of":[13,33,62,99,164,176,196,216,225,242,276,324,370],"patients":[14,93,105,185,201],"develop":[15],"t-NE":[16,26,77,107],"PC,":[17],"which":[18],"is":[19,149,372],"aggressive":[20],"with":[21,57,90,94,106,129,186],"short":[22],"overall":[23],"survival":[24,343],"(OS).":[25],"PC":[27],"treatment":[28,61,74,124,128,261],"includes":[29],"platinum-containing":[30,85],"chemotherapy":[31,86,146,254],"because":[32],"t-NE\u2019s":[34],"histologic,":[35],"biologic,":[36],"and":[37,68,121,143,171,240,294,301,327,340,354,380],"clinical":[38,66],"similarity":[39],"to":[40,83,207,266,320],"small":[41],"cell/NE":[42],"lung":[43],"cancer.":[44],"the":[46,100,252,381],"open-label,":[47],"multicohort,":[48],"phase":[49],"1b/2":[50],"KEYNOTE-365":[51,101,371],"study":[52,102],"(NCT02861573),":[53],"pembrolizumab,":[54],"when":[55],"combined":[56,89],"several":[58],"agents":[59,133],"for":[60,76,92,125,135,147,178,246,264,361],"mCRPC,":[64,78],"showed":[65],"activity":[67],"acceptable":[69],"safety.":[70],"To":[71],"identify":[72],"new":[73],"options":[75],"cohort":[79,154,369],"I":[80,98,155],"will":[81,103,182,202,262,279,358],"help":[82],"evaluate":[84],"alone":[87],"or":[88,141,169,198,251,274],"pembrolizumab":[91,209,257],"t-NE.":[95],"Methods:":[96],"Cohort":[97],"enroll":[104,183],"(\u22651%":[108],"neuroendocrine":[109],"cells":[110],"in":[111,153,374],"a":[112],"recent":[113],"biopsy":[114],"specimen":[115],"confirmed":[116],"by":[117,282,309,335,352],"central":[118,312],"histology":[119],"review)":[120],"prior":[122],"docetaxel":[123,177],"mCRPC.":[126,179],"Prior":[127],"\u22642":[130],"next-generation":[131],"hormonal":[132],"(NHAs)":[134],"hormone-sensitive":[137],"(mHSPC)":[140],"mCRPC":[142,148],"1":[144,215,230],"other":[145],"permitted.":[150],"Additionally,":[151],"enrollment":[152],"requires":[156],"previous":[157],"progression":[160],"within":[161,172],"6":[162,174],"months":[163],"starting":[165],"an":[166],"NHA":[167],"(mHSPC":[168],"mCRPC)":[170],"<":[173],"cycles":[175,248],"Each":[180],"arm":[181,363],"40-100":[184],"Eastern":[187],"Cooperative":[188],"Oncology":[189],"Group":[190,348],"performance":[191],"status":[192],"(ECOG":[193],"PS)":[194],"score":[195,285],"0":[197],"1.":[199],"Eligible":[200],"be":[203,280,359],"randomly":[204],"assigned":[205],"1:1":[206],"receive":[208],"200":[210],"mg":[211],"IV":[212,227,235],"on":[213,228,236],"day":[214,229],"each":[217,243,362],"cycle":[218,245],"every":[219],"3":[220,241],"weeks":[221],"+":[222,231],"carboplatin":[223],"AUC":[224],"5":[226],"etoposide":[232],"100":[233],"mg/m2":[234],"days":[237],"1,":[238],"2,":[239],"21-day":[244],"4":[247],"(arm":[249,258],"1)":[250],"same":[253],"regimen":[255],"without":[256,364],"2).":[259],"Pembrolizumab":[260],"continue":[263],"up":[265],"2":[267],"years":[268],"until":[269],"disease":[270,328],"progression,":[271],"unacceptable":[272],"toxicity,":[273],"withdrawal":[275],"consent.":[277],"Patients":[278],"stratified":[281],"ECOG":[283],"PS":[284],"(0":[286],"vs":[287],"1).":[288],"Primary":[289],"end":[290,316],"points":[291,317,357],"are":[292],"safety":[293],"tolerability,":[295],"prostate-specific":[296],"antigen":[297],"(PSA)":[298],"response":[299,303,325],"rate,":[300],"objective":[302],"rate":[304,330],"(ORR)":[305],"per":[306,332,344],"RECIST":[307,333,350],"v1.1":[308,334,351],"blinded":[310],"independent":[311],"review":[313],"(BICR).":[314],"Secondary":[315],"include":[318],"time":[319],"PSA":[321],"progression;":[322],"duration":[323],"(DOR)":[326],"control":[329],"(DCR)":[331],"BICR;":[336,353],"ORR,":[337],"DOR,":[338],"DCR,":[339],"radiographic":[341],"progression-free":[342],"Prostate":[345],"Cancer":[346],"Working":[347],"3\u2013modified":[349],"OS.":[355],"End":[356],"summarized":[360],"formal":[365],"hypothesis":[366],"testing.":[367],"This":[368],"enrolling":[373],"Australia,":[375],"Germany,":[376],"New":[377],"Zealand,":[378],"Spain,":[379],"United":[382],"States.":[383],"Clinical":[384],"trial":[385],"information:":[386],"NCT02861573.":[387]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2022-02-24T00:00:00"}